The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 95K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brossay, L.
Right arrow Articles by Kronenberg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brossay, L.
Right arrow Articles by Kronenberg, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/10/1521/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 8, October 19, 1998 1521-1528


Articles

CD1d-mediated Recognition of an {alpha}-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution

Laurent Brossay*, Mariacristina Chioda{ddagger}, Nicolas Burdin*, Yasuhiko Koezuka§, Giulia Casorati{ddagger}, Paolo Dellabona{ddagger}, and Mitchell Kronenberg*

From the * La Jolla Institute of Allergy and Immunology, San Diego, California 92121; {ddagger} DIBIT, H.S. Raffaele Institute, I-20132 Milano, Italy; and § Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Gunma 370-12, Japan

Natural killer (NK) T cells are a lymphocyte subset with a distinct surface phenotype, an invariant T cell receptor (TCR), and reactivity to CD1. Here we show that mouse NK T cells can recognize human CD1d as well as mouse CD1, and human NK T cells also recognize both CD1 homologues. The unprecedented degree of conservation of this T cell recognition system suggests that it is fundamentally important. Mouse or human CD1 molecules can present the glycolipid {alpha}-galactosylceramide ({alpha}-GalCer) to NK T cells from either species. Human T cells, preselected for invariant V{alpha}24 TCR expression, uniformly recognize {alpha}-GalCer presented by either human CD1d or mouse CD1. In addition, culture of human peripheral blood cells with {alpha}-GalCer led to the dramatic expansion of NK T cells with an invariant (V{alpha}24+) TCR and the release of large amounts of cytokines. Because invariant V{alpha}14+ and V{alpha}24+ NK T cells have been implicated both in the control of autoimmune disease and the response to tumors, our data suggest that {alpha}-GalCer could be a useful agent for modulating human immune responses by activation of the highly conserved NK T cell subset.

Key Words: CD1 • natural killer T cells • antigen presentation • glycolipid • cytokines


Address correspondence to Mitchell Kronenberg, La Jolla Institute of Allergy and Immunology, 10355 Science Center Dr., San Diego, CA 92121. Phone: 619-678-4540; Fax: 619-678-4595; E-mail: mitch{at}liai.org

Abbreviations used: {alpha}-GalCer, {alpha}-galactosylceramide; β2m, β2-microglobulin; hCD1d, human CD1d; mCD1, mouse CD1.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS